ArticleAdvances in therapy2019

Analysis of Safety, Medical Resource Utilization, and Treatment Costs by Drug Class for Management of Inflammatory Bowel Disease in the United States Based on Insurance Claims Data.

Gráinne H Long et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.